Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Zomedica Pharmaceuticals Corp
ZOMCurrent price
0.12 USD
+0.0002 USD (+0.17%)
Last closed
0.12 USD
Company
www.zomedica.com
ISIN
CA98980M1095
Sector
Healthcare
Industry
Medical Devices
Exchange
NYSE
Capitalization
120 652 152 USD
Yield for 12 month
-35.03 %
1Y
3Y
5Y
10Y
15Y
ZOM
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system. It also provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy. The company has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for the development of a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. is headquartered in Ann Arbor, Michigan. Address: 100 Phoenix Drive, Ann Arbor, MI, United States, 48108
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
0.44 USDP/E ratio
–Dividend Yield
–Current Year
+25 186 000 USD
Last Year
+18 930 000 USD
Current Quarter
+6 131 000 USD
Last Quarter
+6 262 000 USD
Current Year
+17 318 000 USD
Last Year
+13 652 000 USD
Current Quarter
+2 385 000 USD
Last Quarter
+4 117 000 USD
Key Figures ZOM
1 year
3 years
5 years
10 years
EBITDA
-29 393 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-9.29 %
PEG Ratio
–
Return On Equity TTM
-23.92 %
Wall Street Target Price
0.44 USD
Revenue TTM
26 077 000 USD
Book Value
0.21 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
1.8 %
Dividend Yield
–
Gross Profit TTM
13 652 000 USD
Earnings per share
-0.06 USD
Diluted Eps TTM
-0.06 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-214.7 %
Dividend Analytics ZOM
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ZOM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation ZOM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
1.6657
Price Sales TTM
4.6268
Enterprise Value EBITDA
-7.1918
Price Book MRQ
0.5781
Financials ZOM
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ZOM
For 52 weeks
0.12 USD
0.23 USD
50 Day MA
0.13 USD
Shares Short Prior Month
43 371 169
200 Day MA
0.14 USD
Short Ratio
17.24
Shares Short
51 140 313
Short Percent
5.21 %
BeatStart